Depression care among depressed adults with and without comorbid substance use disorders in the United States

Depression and Anxiety

Volumn 34, Issue 3, 2017, Pages 291-300

  Han, Beth ^a   Olfson, Mark ^b,c   Mojtabai, Ramin ^d,e  

^a SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

^b Columbia University ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

addiction; antidepressants; depression; drug abuse; mood disorders; primary care; substance use disorders; treatment

Indexed keywords

ADDICTION; ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG DEPENDENCE; EDUCATION; ETHNIC GROUP; FEMALE; FUNCTIONAL DISEASE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; PREVALENCE; PRIMARY MEDICAL CARE; RACE; RACE RELATION; SUICIDAL IDEATION; UNITED STATES; ADOLESCENT; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 85011660618     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22592     Document Type: Article

References (38)

1. American Association for Public Opinion Research. (2015). Standard definitions: Final dispositions of case codes and outcome rates for surveys (8th ed., pp. 52–53). Lenexa, KS: American Association for Public Opinion Research.
2. American Psychiatry Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed., pp. 175–392). Washington DC: American Psychiatry Association.
3. Barry, C. L., & Huskamp, H. A. (2011). Moving beyond parity—Mental health and addiction care under the ACA. New England Journal of Medicine, 365(11), 973–975.
4. Bieler, G. S., Brown, G. G., Williams, R. L., & Brogan, D. J. (2010). Estimating model-adjusted risks, risk differences, and risk ratio from complex survey data. American Journal of Epidemiology, 171(5), 618–623.
5. Bishop, T. F., Press, M. J., Keyhani, S., & Pincus, H. A. (2014). Acceptance of insurance by psychiatrists and the implications for access to mental health care. JAMA Psychiatry, 71(2), 176–181.
6. Blanco, C., Alegría, A. A., Liu, S. M., Secades-Villa, R., Sugaya, L., Davies, C., & Nunes, E. V. (2012). Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 73(6), 865–873.
7. Buck, J. A. (2011). The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Affairs 30(8), 1402–1410.
8. Clark, R. E., Samnaliev, M., & McGovern, M. P. (2009). Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders. Psychiatric Services, 60(1), 35–42.
9. Compton, W. M., Blanco, C., & Wargo, E. M. (2015). Integrating addiction services into general medicine. Journal of the American Medical Association, 314(22), 2401–2402.
10. Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(5), 566–576.
11. Crum, R. M., Mojtabai, R., Lazareck, S., Bolton, J. M., Robinson, J., Sareen, J., … Storr, C. L. (2013). A prospective assessment of reports of drinking to self-medicate mood symptoms with the incidence and persistence of alcohol dependence. JAMA Psychiatry, 70(7), 718–726.
12. Frasure-Smith, N., Lesperance, F., & Talajic, M. (1993). Depression following myocardial infarction: Impact on 6-month survival. Journal of the American Medical Association, 270(15), 1819–1825.
13. Goldstein, R. Z., Craig, A. D., Bechara, A., Garavan, H., Childress, A. R., Paulus, M. P., Volkow, N. D. (2009). The neurocircuitry of impaired insight in drug addiction. Trends in Cognitive Sciences, 13(9), 372–380.
14. Grant, B. F., Saha, T. D., Ruan, W. J., Goldstein, R. B., Chou, S. P., Jung, J. … Hasin, D. S. (2016). Epidemiology of DSM-5 drug use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry, 73(1), 39–47.
15. Han, B., Hedden, S. L., Lipari, R., Copello, E. A. P., Krouti, L. A., (2016). Receipt of services for behavioral health problems: Results from the 2014 National Survey on Drug Use and Health. NSDUH data review. Retrieved from, May 20, http://www.samhsa.gov/data/sites/default/files/NSDUH-DR-FRR3-2014/NSDUH-DR-FRR3-2014/NSDUH-DR-FRR3-2014.htm
16. Han, B., McKeon, R., & Gfroerer, J. (2014). Suicidal ideation among community-dwelling adults in the United States. American Journal of Public Health, 104(3), 488–497.
17. Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry, 62(10), 1097–1106.
18. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R. … Wang, P. S. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association, 289(23), 3095–3105.
19. Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627.
20. Lazareck, S., Robinson, J. A., Crum, R. M., Mojtabai, R., Sareen, J., & Bolton, J. M. (2012). A longitudinal investigation of the role of self-medication in the development of comorbid mood and drug use disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Clinical Psychiatry, 73(5), 588–593.
21. Leon, A. C., Olfson, M., Portera, L., Farber, L., & Sheehan, D. V. (1997). Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. International Journal of Psychiatry in Medicine, 27(2), 93–105.
22. Mojtabai, R., Chen, L. Y., Kaufmann, C. N., & Crum, R. M. (2014). Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders. Journal of Substance Abuse Treatment, 46(2), 268–273.
23. Mojtabai, R., Olfson, M., & Mechanic, D. (2002). Mental disorders, perceived need and help seeking in the community. Archives of General Psychiatry, 5, 77–84.
24. O'Donnell, A. N., Williams, M., & Kilbourne, A. M. (2013). Overcoming roadblocks: Current and emerging reimbursement strategies for integrated mental health services in primary care. Journal of General Internal Medicine, 28(12), 1667–1672.
25. Olfson, M., Kroenke, K., Wang, S., & Blanco, C. (2014). Trends in office-based mental health care provided by psychiatrists and primary care physicians. Journal of Clinical Psychiatry, 75(3), 247–253.
26. Olfson, M., Liu, S., Grant, B. F., & Blanco, C. (2012). Influence of comorbid mental disorders on time to treatment seeking for major depressive disorder. Medical Care, 50(3), 227–232.
27. Pan, A., Sun, Q., Okereke, O. I., Rexrode, K. M., & Hu, F. B. (2011). Depression and risk of stroke morbidity and mortality. A meta-analysis and systematic review. Journal of the American Medical Association, 306(11), 1241–1249.
28. Pincus, H. A., Pechura, C. M., & Elinson, L. (2001). Depression in primary care: Linking clinical and systems strategies. General Hospital Psychiatry, 23(6), 311–318.
29. Research Triangle Institute. (2015). SUDAAN Release 11.0.1. Research Triangle Park, NC: RTI International. Retrieved from, May 20, https://www.rti.org/page.cfm/SUDAAN_Eleven_One
30. Sederer, L. I., & Sharfstein, S. S. (2014). Fixing the troubled mental health system. Journal of the American Medical Association, 312(12), 1195–1196.
31. Siu, A. L., the US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., & … Pignone, M. P. (2016). Screening for depression in adults. US Preventive Services Task Force Recommendation Statement. Journal of the American Medical Association, 315(4), 380–387.
32. Substance Abuse and Mental Health Services Administration. (2016). National Survey on Drug Use and Health. Retrieved from, May 20, http://www.samhsa.gov/data/population-data-nsduh/reports
33. Tai, B., & Volkow, N. D. (2013). Treatment for substance use disorder: Opportunities and challenges under the affordable care act. Social Work in Public Health, 28(3-4), 165–174.
34. Tolliver, B. K., & Anton, R. F. (2015). Assessment and treatment of mood disorders in the context of substance abuse. Dialogues in Clinical Neuroscience, 17(2), 181–190.
35. U.S. Department of Health and Human Services (2016). Administration issues final mental health and substance use disorder parity rule. Retrieved from, April 20, http://www.hhs.gov/news/press/2013pres/11/20131108b.html Accessed on.
36. Wang, P. S., Berglund, P., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005). Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 603–613.
37. Wang, P. S., Demler, O., & Kessler, R. C. (2002). Adequacy of treatment for serious mental illness in the United States. American Journal of Public Health, 92(1), 92–98.
38. Watkins, K. E., Hunter, S. B., Burnam, M. A., Pincus, H. A., & Nicholson, G. (2005). Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder. Psychiatric Services 56(8), 913–926.